CBS: HRT Gets New Attention as FDA Changes Menopause Warning Guidance (Aug 2026)
Tier 2: Professional organization or credentialed expert guidance
Publisher: CBS News (CBS Texas, Erin Jones) · Published: August 26, 2026 ·
Accessed: August 26, 2026
Visit the source ↗
Claims this source supports
- Late last year the FDA began removing long-standing black-box warnings from some hormone replacement therapy products, and local medical professionals say more women are now asking about them (CBS Texas, updated Aug 26 2026).
- For more than two decades many HRT products carried the FDA's strongest warning, a black-box warning; guidance had been 'lowest dose for the shortest amount of time' over fears including breast cancer, strokes, and heart attacks (CBS Texas, Aug 26 2026, quoting Texas Health Presbyterian Hospital Dallas OB-GYN Dr. Emil Tajzoy).
- Dr. Tajzoy says many of those concerns date back to the WHI study more than 20 years ago and that the hormones used in that study were not human bioidentical hormones; studies of bioidentical hormones show 'a massive decreased risk in basically all the things that the original study said we had to worry about' (CBS Texas, Aug 26 2026).
- Treatment should be individualized based on a woman's symptoms, age, health history, and risk factors; for women who can't or don't want hormones there are non-hormonal prescription medications that primarily target individual symptoms and don't replace hormones (CBS Texas, Aug 26 2026).